Beneficat en es it fr

Beneficat Brand names, Beneficat Analogs

Beneficat Brand Names Mixture

  • No information avaliable

Beneficat Chemical_Formula


Beneficat RX_link

Beneficat fda sheet

Beneficat FDA

Beneficat msds (material safety sheet)

Beneficat Synthesis Reference

Palazzo, Silvestrini, U.S. Pat 3,381,009 (1968)

Beneficat Molecular Weight

371.864 g/mol

Beneficat Melting Point

86-87 oC

Beneficat H2O Solubility

Sparigly soluble

Beneficat State


Beneficat LogP


Beneficat Dosage Forms


Beneficat Indication

For the treatment of depression.

Beneficat Pharmacology

Trazodone is an antidepressant and hypnotic chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. The mechanism of trazodone's antidepressant action in man is not fully understood. In animals, trazodone selectively inhibits serotonin uptake by brain synaptosomes and potentiates the behavioral changes induced by the serotonin precursor, 5-hydroxytryptophan. Cardiac conduction effects of trazodone in the anesthetized dog are qualitatively dissimilar and quantitatively less pronounced than those seen with tricyclic antidepressants. Trazodone is not a monoamine oxidase inhibitor and, unlike amphetamine-type drugs, does not stimulate the central nervous system. In man, trazodone is well absorbed after oral administration without selective localization in any tissue. Since the clearance of trazodone from the body is sufficiently variable, in some patients trazodone may accumulate in the plasma.

Beneficat Absorption

Well absorbed following oral administration.

Beneficat side effects and Toxicity

LD50=96mg/kg (i.v. in mice)

Beneficat Patient Information

Beneficat Organisms Affected

Humans and other mammals